8-K filed Apr 29, 2026 at 06:25 ET
GE HealthCare reported Q1 2026 revenue of $5.13B (+7.4% YoY) and GAAP diluted EPS of $0.85, down from $1.23 YoY. Adjusted EPS was $0.99 vs $1.01 YoY, missing the $1.07 consensus. The company lowered full-year 2026 Adjusted EBIT margin guidance to 15.4%-15.7% (from 15.8%-16.1%), Adjusted EPS guidance to $4.80-$5.00 (from $4.95-$5.15), and Free Cash Flow guidance to ~$1.6B (from ~$1.7B), citing inflation in memory chips, oil, and freight costs plus a PDx supplier issue. The lowered guidance and earnings miss are the primary negative signals.